Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Alimentary Pharmacology & Therapeutics
|
November 26, 1999
Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis
M Schepke, P Raab, A Hoppe, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 4, 1997
[The Churg-Strauss syndrome with cerebral seizures and terminal kidney failure]
B Terjung, W D Paar, M Schepke, et al.
Gastroenterology
|
January 29, 1999
Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis
J Heller, M Schepke, N Gehnen, et al.
European Journal of Clinical Investigation
|
March 19, 2003
Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteries
M Neef, E Biecker, J Heller, et al.
Scandinavian Journal of Gastroenterology
|
October 11, 2002
Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt
K A Brensing, M Hörsch, J Textor, et al.
Abdominal Imaging
|
February 9, 2006
Magnetic resonance (MR) imaging and MR angiography for evaluation and follow-up of hepatic artery banding in patients with hepatic involvement of hereditary hemorrhagic telangiectasia
W A Willinek, D Hadizadeh, M von Falkenhausen, et al.
Hepatology (Baltimore, Md.)
|
October 27, 2001
Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism
M Schepke, J Heller, S Paschke, et al.
Zeitschrift Fur Gastroenterologie
|
June 4, 2011
[German S 3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome"]
A L Gerbes, V Gülberg, T Sauerbruch, et al.
Endoscopy
|
April 6, 2006
Biliary metal stents and air embolism: a note of caution
C Rabe, Z Balta, U Wüllner, et al.
Gastroenterology
|
August 7, 2001
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
M Schepke, E Werner, E Biecker, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Alimentary Pharmacology & Therapeutics
|
November 26, 1999
Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis
M Schepke, P Raab, A Hoppe, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 4, 1997
[The Churg-Strauss syndrome with cerebral seizures and terminal kidney failure]
B Terjung, W D Paar, M Schepke, et al.
Gastroenterology
|
January 29, 1999
Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis
J Heller, M Schepke, N Gehnen, et al.
European Journal of Clinical Investigation
|
March 19, 2003
Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteries
M Neef, E Biecker, J Heller, et al.
Scandinavian Journal of Gastroenterology
|
October 11, 2002
Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt
K A Brensing, M Hörsch, J Textor, et al.
Abdominal Imaging
|
February 9, 2006
Magnetic resonance (MR) imaging and MR angiography for evaluation and follow-up of hepatic artery banding in patients with hepatic involvement of hereditary hemorrhagic telangiectasia
W A Willinek, D Hadizadeh, M von Falkenhausen, et al.
Hepatology (Baltimore, Md.)
|
October 27, 2001
Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism
M Schepke, J Heller, S Paschke, et al.
Zeitschrift Fur Gastroenterologie
|
June 4, 2011
[German S 3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome"]
A L Gerbes, V Gülberg, T Sauerbruch, et al.
Endoscopy
|
April 6, 2006
Biliary metal stents and air embolism: a note of caution
C Rabe, Z Balta, U Wüllner, et al.
Gastroenterology
|
August 7, 2001
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
M Schepke, E Werner, E Biecker, et al.
Page
of 4